image
Neogen Corporation NEOG
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
Watchlist
$ 14.6
-0.273 %
$ 3.16 B
Market Cap
-132.73
P/E
INCOME STATEMENT
924 M REVENUE
12.37%
Growth Rates
1Year 12.37%
3Years 25.42%
5Years 17.41%
7Years 14.35%
10Years 14.09%
58.7 M OPERATING INCOME
56.37%
Growth Rates
1Year 56.37%
3Years 3.36%
5Years 3.05%
7Years -1.44%
10Years 3.06%
-9.42 M NET INCOME
58.81%
Growth Rates
1Year 58.81%
3Years -4.91%
5Years -2.95%
7Years -2.81%
10Years -2.94%
EFFICIENCY
Earnings Waterfall Neogen Corporation
image
Revenue 924 M
Cost Of Revenue 460 M
Gross Profit 464 M
Operating Expenses 405 M
Operating Income 58.7 M
Other Expenses 68.1 M
Net Income -9.42 M

Income Statement

Millions
May-2024 May-2023 May-2022 May-2021 May-2020 May-2019 May-2018 May-2017 May-2016 May-2015 May-2014 May-2013 May-2012 May-2011 May-2010 May-2009 May-2008 May-2007 May-2006 May-2005 May-2004 May-2003 May-2002 May-2001 May-2000 May-1999 May-1998 May-1997 May-1996 May-1995 May-1994 May-1993 May-1992 May-1991 May-1990 May-1989 May-1988
REVENUE
Revenue 924.2 822.4 527.2 468.5 418.2 414.2 402.3 361.6 321.3 283.1 247.4 207.5 184.0 172.7 140.5 118.7 102.4 86.1 72.4 62.8 55.5 46.5 41.1 34.9 23.5 22.2 18.5 15.3 12.5 11.7 10.7 7.6 6.6 6.0 6.0 6.2 4.8
GROSS PROFIT
Cost Of Revenue 460.3 416.5 284.1 253.4 221.9 222.3 212.0 189.6 168.2 143.4 124.8 98.0 91.6 84.9 67.5 59.3 49.2 41.6 35.4 32.2 28.0 21.8 20.2 17.2 9.9 8.6 7.2 5.6 5.0 4.7 4.3 3.5 3.4 3.1 3.1 3.0 2.7
Gross Profit 463.9 406.0 243.0 215.1 196.3 191.9 190.3 172.0 153.1 139.7 122.6 109.5 92.4 87.8 73.0 59.4 53.2 44.6 37.0 30.6 27.5 24.7 20.9 17.7 13.6 13.6 11.3 9.7 7.5 7.0 6.4 4.1 3.2 2.9 2.9 3.2 2.1
OPERATING INCOME
Operating Expenses 405.2 368.4 184.4 140.9 128.8 123.8 120.1 107.0 96.7 86.6 79.2 68.8 58.7 52.0 46.1 38.9 35.2 31.1 25.0 21.8 20.0 17.9 15.4 13.5 11.2 11.0 9.7 8.3 7.0 6.4 5.5 4.8 4.2 4.1 3.9 3.4 2.9
Selling, General and Administrative Expenses 382.8 342.4 167.3 124.6 114.0 111.0 109.2 96.6 86.8 77.0 70.9 61.0 52.0 45.1 39.8 34.4 31.6 27.8 22.0 19.1 17.1 15.0 13.1 11.6 8.7 8.5 7.6 6.4 5.3 5.9 5.1 4.5 3.9 3.9 3.6 3.1 2.6
Research and Development Expenses 22.5 26.0 17.0 16.2 14.8 12.8 10.9 10.4 9.9 9.6 8.3 7.8 6.6 6.8 6.3 4.6 3.6 3.3 3.0 2.7 2.9 2.9 2.3 1.8 1.6 1.6 1.4 1.3 1.2 0 0 0 0 0 0 0 0
Operating Income 58.7 37.5 34.9 53.1 49.1 50.5 70.2 64.9 56.4 53.1 43.4 40.7 33.7 35.8 26.9 20.5 18.0 13.5 12.0 8.8 7.5 6.8 5.5 4.3 2.4 2.6 1.6 1.4 0.5 0.6 0.9 (0.7) (1.0) (1.2) (1.0) (0.2) (0.8)
PRE-TAX INCOME
Interest Income Expense 73.4 56.0 1.3 78 K 0 0 0 0 0 0 0 0 0 0 0 0 0 (15.0) (283.0) (83.0) (61.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Other Income (73.0) (59.6) 1.6 1.1 4.8 4.9 3.3 1.7 (0.9) (1.0) (0.4) 0.4 0.2 (0.6) 0.4 1.1 0.5 0.4 46 K 0.1 0.1 0.5 0.5 0.6 1.9 100 K 0.7 0.5 (0.5) 0.2 0 0.2 0.2 0.6 1.0 0 100 K
Pre-Tax Income (14.3) (22.0) 60.2 75.3 72.3 73.0 73.5 66.7 55.5 52.1 43.0 41.1 34.0 35.2 27.3 21.6 18.5 13.9 12.1 8.9 7.7 7.3 6.0 4.9 4.3 2.7 2.3 1.9 0 0.8 0 (0.5) (0.8) (0.6) 0 0 (0.9)
NET INCOME
Tax Provision (4.9) 0.8 11.9 14.4 12.8 12.8 10.2 22.7 19.0 18.5 15.0 14.1 11.4 12.4 9.8 7.8 6.4 4.8 4.2 3.0 2.6 2.5 2.0 1.7 1.2 0.4 100 K 100 K 0.7 100 K 0 (0.2) (0.2) (0.4) (0.8) 0.3 0.3
Net Income (9.4) (22.9) 48.3 60.9 59.5 60.2 63.1 43.8 36.6 33.5 28.2 27.2 22.5 22.8 17.5 13.9 12.1 9.1 7.9 5.9 5.1 4.8 3.9 3.2 3.1 2.3 2.2 1.8 (0.2) 0.7 0.9 (0.5) (0.8) (0.8) (0.2) (0.5) (1.1)
EPS 0.0435 0.12 0.45 0.57 0.57 0.58 0.61 0.43 0.36 0.34 0.29 0.28 0.24 0.25 0.19 0.16 0.14 0.11 0.0944 0.0683 0.0583 0.0567 0.0587 0.0489 0.0462 0.0329 0.032 0.0284 0.0056 0.0133 0.0169 0.0116 0.0187 0.0178 0.0044 0.0205 0.0534